Introducing Q Amyloid: a tool for automated PET‐based amyloid‐beta quantification
Q Amyloid will be a valuable tool, both in supporting medical research to identify and track AD in its early stages and in providing pharmacodynamic biomarkers for developing anti-amyloid therapies. Furthermore, it will facilitate the analysis of new clinical data, making it operative on an international basis. The platform will enable the maximization of methodology sharing and reusability in a decentralized manner. This project is supported by the cascading grant "Q Amyloid - Quantitative Amyloid Imaging" under PNRR ECS00000017 "THE - Tuscany Health Ecosystem," Spoke 6: "Precision Medicine & Personalized Healthcare" funded by the European Commission through the NextGeneration EU plan.
Authors
- Luigi Lorenzini (ORCID: https://orcid.org/0000-0002-9756-881X)
- Mattia Veronese (ORCID: https://orcid.org/0000-0003-3562-0683)
- Manuela Moretto (ORCID: https://orcid.org/0000-0003-4178-1854)
- Francesco Piva (ORCID: https://orcid.org/0000-0003-3620-5510)
- Lucia Maccioni (ORCID: https://orcid.org/0000-0002-6564-2827)
- Benedetta Marin
- Chiara Da Villa
Institutions
- University of Padua (IT)
- King's College London (GB)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70862_110093
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission